PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic JournalOpen Access

Molecules

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Molecules has 1 tracked paper indexed in Blossom (2020) from 2 authors, most often covering Psilocybin and DMT, across Major Depressive Disorder (MDD), Depressive Disorders and Immunology & Inflammation.

Published Papers

Open Accessmeta

Natural Psychoplastogens As Antidepressant Agents

This review (2020) explored recent advances in natural psychoplastogens (psychedelics) as antidepressant agents. The study noted that these compounds are effective in rapid structural and functional rearrangement of neural systems by targeting mechanisms that were previously implicated in the development of depression. The study observed the evidence that they expend potent acute and long-term positive effects, beyond the treatment of psychiatric disorders with many of them being naturally occurring compounds, like psilocybin and DMT.

Published
March 5, 2020
Journal
Molecules
Authors
Benko, J., Vranková, S.

Quick Facts

Papers Indexed
1
h-Index
261
Open Access
Yes
Publisher
MDPI
Country
Switzerland
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.